Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Rhabdomyolysis

fluorodeoxyglucose f18 has been researched along with Rhabdomyolysis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chen, L; Guo, C; Huang, Z; Liu, Y1
Hainaut, P; Roelants, V; Yildiz, H1
Israel, DA; Sheehy, N1

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Rhabdomyolysis

ArticleYear
68Ga-FAPI PET/CT in a Patient With Statin-Induced Rhabdomyolysis.
    Clinical nuclear medicine, 2023, Jan-01, Volume: 48, Issue:1

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Rhabdomyolysis

2023
Statin-induced rhabdomyolysis mimicking polymyositis on (18)F-FDG PET imaging.
    Acta clinica Belgica, 2015, Volume: 70, Issue:2

    Topics: Aged, 80 and over; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Polymyositis; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyolysis

2015
Findings on (18)FDG-PET imaging in statin-induced rhabdomyolysis.
    Clinical radiology, 2007, Volume: 62, Issue:10

    Topics: Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rhabdomyolysis

2007